Brentwood, Tenn.-based Surgery Partners reported $3.3 billion in revenue for 2025, a 6.2% increase year over year, according to an earnings report released March 2.
Here are 10 things to know:
- Fourth-quarter revenue rose 2.4% to $885 million.
- Same-facility revenue increased 3.5% in Q4 compared to the year prior and 4.9% for the full year.
- Surgical cases declined 2.1% in the fourth quarter but rose 2% across 2025. Same-facility cases rose 1.3% in Q4 and 3.4% annually.
- The company reported a net loss of $15 million in Q4 and $77.9 million for the year.
- Adjusted EBITDA was $156.9 million in Q4, down 4.2%, and $526.2 million for the year, up 3.5%.
- Full-year operating cash flow was $274.3 million, down from $300.1 million in 2024.
- The company ended 2025 with $239.9 million in cash and $692.8 million in revolving credit capacity.
- Facility count grew to 176 surgical sites, up from 161 the year prior.
- On Feb. 26, the board authorized a share repurchase program of up to $200 million.
10. Surgery Partners issued 2026 guidance of at least $530 million in adjusted EBITDA and revenue between $3.35 billion and $3.45 billion.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.